Stock ScreenerStock IdeasZen Ratings + Top AnalystsStocks With a Zen Rating of A + Top Analyst consensus of Strong Buy + Large Upside in Target Price: Feb 12, 2026The 2 best sources of winning stocks is the Zen Ratings and our analysis of Top Analysts from Wall Street. Now we have combined them together in a best of both worlds approach to find stocks with the best upside potential.
Stock ScreenerStock IdeasZen Ratings + Top Analysts
Zen Rating: A
Upside/Downside: Large Upside
Top Analysts Consensus: Strong Buy
| Ticker | Company | Exchange | Industry | Zen Rating | Market Cap | Price | 1d % | EBITDA | P/E | D/E | Country | DD Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ALNY | ALNYLAM PHARMACEUTICALS INC | NASDAQ | Biotechnology | A | $42.51B | $321.75 | -0.38% | $151.92M | 1,037.90x | 19.74 | United States | 43 |
| LTM | LATAM AIRLINES GROUP SA | NYSE | Airlines | A | $37.09B | $61.37 | 0.34% | $1.88B | 18.99x | 20.11 | Chile | 40 |
| JLL | JONES LANG LASALLE INC | NYSE | Real Estate Services | A | $14.31B | $303.11 | -12.46% | $1.16B | 22.76x | 1.38 | United States | 43 |
| JAZZ | JAZZ PHARMACEUTICALS PLC | NASDAQ | Biotechnology | A | $10.10B | $166.24 | 0.37% | $182.64M | -27.75x | 1.87 | Ireland | 16 |
| BCO | BRINKS CO | NYSE | Security & Protection Services | A | $5.43B | $130.73 | -0.58% | $806.70M | 32.76x | 24.42 | United States | 44 |
| INDV | INDIVIOR PLC | NASDAQ | Drug Manufacturers - Specialty & Generic | A | $4.26B | $34.08 | 1.85% | $316.00M | 26.02x | -7.84 | United Kingdom | 36 |
| VISN | VISTANCE NETWORKS INC | NASDAQ | Communication Equipment | A | $4.25B | $19.17 | -1.24% | $1.70B | 4.68x | -3.84 | United States | 24 |
| RSI | RUSH STREET INTERACTIVE INC | NYSE | Gambling | A | $3.92B | $17.10 | -1.55% | -$33.04M | 51.82x | 2.40 | United States | 53 |
| VCYT | VERACYTE INC | NASDAQ | Biotechnology | A | $2.84B | $35.99 | -2.81% | $57.00M | 92.28x | 0.09 | United States | 45 |
| HCI | HCI GROUP INC | NYSE | Insurance - Property & Casualty | A | $2.14B | $164.77 | 1.22% | $301.16M | 9.55x | 1.82 | United States | 50 |
| HLMN | HILLMAN SOLUTIONS CORP | NASDAQ | Tools & Accessories | A | $2.03B | $10.30 | 0.19% | $249.21M | 51.50x | 0.95 | United States | 41 |
| FIVN | FIVE9 INC | NASDAQ | Software - Infrastructure | A | $1.30B | $16.59 | -6.64% | $127.81M | 39.50x | 1.28 | United States | 58 |
| DFIN | DONNELLEY FINANCIAL SOLUTIONS INC | NYSE | Capital Markets | A | $1.10B | $41.27 | -7.01% | $119.00M | 37.18x | 0.93 | United States | 42 |
| TBLA | TABOOLACOM LTD | NASDAQ | Internet Content & Information | A | $979.96M | $3.40 | -2.86% | $137.29M | 42.50x | 0.68 | United States | 45 |
| UVE | UNIVERSAL INSURANCE HOLDINGS INC | NYSE | Insurance - Property & Casualty | A | $888.59M | $31.68 | 0.89% | $174.52M | 7.23x | 5.24 | United States | 39 |
| MNTN | MNTN INC | NYSE | Software - Application | A | $816.44M | $11.15 | 37.15% | N/A | N/A | 0.26 | United States | 13 |
| NRDS | NERDWALLET INC | NASDAQ | Internet Content & Information | A | $703.86M | $9.68 | -5.74% | $98.00M | 9.98x | 0.23 | United States | 55 |
| BWMN | BOWMAN CONSULTING GROUP LTD | NASDAQ | Engineering & Construction | A | $619.35M | $35.65 | 0.00% | $38.00M | 36.38x | 0.95 | United States | 54 |
| ORGO | ORGANOGENESIS HOLDINGS INC | NASDAQ | Drug Manufacturers - Specialty & Generic | A | $477.19M | $3.76 | -2.08% | $18.04M | -31.33x | 0.49 | United States | 20 |
| LTRX | LANTRONIX INC | NASDAQ | Communication Equipment | A | $228.23M | $5.75 | -7.56% | -$4.74M | -25.00x | 0.64 | United States | 17 |
| FENC | FENNEC PHARMACEUTICALS INC | NASDAQ | Biotechnology | A | $219.87M | $7.82 | 0.39% | -$4.53M | -31.28x | -11.97 | United States | 30 |
| ELMD | ELECTROMED INC | NYSEMKT | Medical Devices | A | $209.03M | $25.26 | -9.98% | $13.13M | 23.61x | 0.21 | United States | 51 |
| INFU | INFUSYSTEM HOLDINGS INC | NYSEMKT | Medical Instruments & Supplies | A | $154.76M | $7.61 | 0.00% | $24.16M | 29.27x | 0.78 | United States | 45 |
Upgrade to Premium to View More
Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More
Already have access to Premium? Sign In
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.